164 related articles for article (PubMed ID: 20614156)
1. The requirement for a sufficient period of corticosteroid treatment in combination with nucleoside analogue for severe acute exacerbation of chronic hepatitis B.
Fujiwara K; Yasui S; Okitsu K; Yonemitsu Y; Oda S; Yokosuka O
J Gastroenterol; 2010 Dec; 45(12):1255-62. PubMed ID: 20614156
[TBL] [Abstract][Full Text] [Related]
2. Virological efficacy of combination therapy with corticosteroid and nucleoside analogue for severe acute exacerbation of chronic hepatitis B.
Yasui S; Fujiwara K; Nakamura M; Miyamura T; Yonemitsu Y; Mikata R; Arai M; Kanda T; Imazeki F; Oda S; Yokosuka O
J Viral Hepat; 2015 Feb; 22(2):94-102. PubMed ID: 24750410
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of combination therapy of antiviral and immunosuppressive drugs for the treatment of severe acute exacerbation of chronic hepatitis B.
Fujiwara K; Yasui S; Yonemitsu Y; Fukai K; Arai M; Imazeki F; Suzuki A; Suzuki H; Sadahiro T; Oda S; Yokosuka O
J Gastroenterol; 2008; 43(9):711-9. PubMed ID: 18807133
[TBL] [Abstract][Full Text] [Related]
4. Corticosteroid and nucleoside analogue for hepatitis B virus-related acute liver failure.
Fujiwara K; Yasui S; Yokosuka O
World J Gastroenterol; 2015 Sep; 21(36):10485-6. PubMed ID: 26420977
[TBL] [Abstract][Full Text] [Related]
5. Importance of adequate immunosuppressive therapy for the recovery of patients with "life-threatening" severe exacerbation of chronic hepatitis B.
Fujiwara K; Yokosuka O; Kojima H; Kanda T; Saisho H; Hirasawa H; Suzuki H
World J Gastroenterol; 2005 Feb; 11(8):1109-14. PubMed ID: 15754390
[TBL] [Abstract][Full Text] [Related]
6. Early Combination Therapy with Corticosteroid and Nucleoside Analogue Induces Rapid Resolution of Inflammation in Acute Liver Failure due to Transient Hepatitis B Virus Infection.
Fujiwara K; Yasui S; Haga Y; Nakamura M; Yonemitsu Y; Arai M; Kanda T; Oda S; Yokosuka O; Kato N
Intern Med; 2018 Jun; 57(11):1543-1552. PubMed ID: 29321429
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of lamivudine treatment in patients with severe acute exacerbation of hepatitis B e antigen (HBeAg)-positive chronic hepatitis B.
Wong VW; Wong GL; Tsang SW; Hui AY; Chim AM; Yiu KK; Chan HY; Chan FK; Sung JJ; Chan HL
Antivir Ther; 2008; 13(4):571-9. PubMed ID: 18672536
[TBL] [Abstract][Full Text] [Related]
8. Combined glucocorticoid and antiviral therapy of hepatitis B virus-related liver failure.
Bockmann JH; Dandri M; Lüth S; Pannicke N; Lohse AW
World J Gastroenterol; 2015 Feb; 21(7):2214-9. PubMed ID: 25717260
[TBL] [Abstract][Full Text] [Related]
9. Determinants of the clinical outcome of patients with severe acute exacerbation of chronic hepatitis B virus infection.
Mori N; Suzuki F; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saito S; Suzuki Y; Arase Y; Ikeda K; Kobayashi M; Kumada H
J Gastroenterol; 2012 Sep; 47(9):1022-9. PubMed ID: 22370817
[TBL] [Abstract][Full Text] [Related]
10. A Dynamic Model for Predicting Outcome in Patients with HBV Related Acute-On-Chronic Liver Failure.
Lin W; Zhang J; Liu X; Liu H; He J; Li M; Zhang S; Zhang Y; Chen H; Zhang C; Wu W; Jin C; Lee SS; Duan Z
Ann Hepatol; 2018; 17(3):392-402. PubMed ID: 29735787
[TBL] [Abstract][Full Text] [Related]
11. Short-term entecavir therapy of chronic severe hepatitis B.
Chen J; Han JH; Liu C; Yu RH; Li FZ; Li QF; Gong GZ
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):261-6. PubMed ID: 19502165
[TBL] [Abstract][Full Text] [Related]
12. Short-term entecavir versus lamivudine therapy for HBeAg-negative patients with acute-on-chronic hepatitis B liver failure.
Lai J; Yan Y; Mai L; Zheng YB; Gan WQ; Ke WM
Hepatobiliary Pancreat Dis Int; 2013 Apr; 12(2):154-9. PubMed ID: 23558069
[TBL] [Abstract][Full Text] [Related]
13. Treatment of chronic hepatitis B: case selection and duration of therapy.
Leung N
J Gastroenterol Hepatol; 2002 Apr; 17(4):409-14. PubMed ID: 11982721
[TBL] [Abstract][Full Text] [Related]
14. Use of nucleoside (tide) analogues in patients with hepatitis B-related acute liver failure.
Dao DY; Seremba E; Ajmera V; Sanders C; Hynan LS; Lee WM;
Dig Dis Sci; 2012 May; 57(5):1349-57. PubMed ID: 22198704
[TBL] [Abstract][Full Text] [Related]
15. A combination treatment of entecavir and early-phase corticosteroid in severe exacerbation of chronic hepatitis B.
Matsumoto K; Miyake Y; Miyatake H; Takahara M; Imada T; Yagi S; Toyokawa T; Nakatsu M; Ando M; Hirohata M
World J Gastroenterol; 2009 Apr; 15(13):1650-2. PubMed ID: 19340912
[TBL] [Abstract][Full Text] [Related]
16. Varying 10-year off-treatment responses to nucleos(t)ide analogues in patients with chronic hepatitis B according to their pretreatment hepatitis B e antigen status.
Liu F; Liu ZR; Li T; Liu Y; Zhang M; Xue Y; Zhang LX; Ye Q; Fan XP; Wang L
J Dig Dis; 2018 Sep; 19(9):561-571. PubMed ID: 30098114
[TBL] [Abstract][Full Text] [Related]
17. Treatment of pegylated interferon-α2a in chronic hepatitis B patients demonstrating a spontaneous decline in HBV DNA after acute exacerbation.
Cai Q; Chen F; Shao X; Zhang X; Zhao Z; Gao Z
Antivir Ther; 2015; 20(2):217-24. PubMed ID: 25138110
[TBL] [Abstract][Full Text] [Related]
18. Viral activity and outcome of hepatitis B surface antigen-positive grafts in deceased liver transplantation.
Lee WC; Chou HS; Lee CS; Wu TH; Wang YC; Cheng CH; Lee CF; Wu TJ; Chan KM
J Viral Hepat; 2018 Jul; 25(7):874-877. PubMed ID: 29431877
[TBL] [Abstract][Full Text] [Related]
19. [The short-term efficacy of nucleoside analogue on the treatment of acute-on-chronic liver failure].
Liu XY; Wang HF; Hu JH; He WP; Wang HQ; Liu N
Zhonghua Gan Zang Bing Za Zhi; 2010 Nov; 18(11):845-8. PubMed ID: 21138634
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of tenofovir-based rescue therapy for patients with drug-resistant chronic hepatitis B].
Choi K; Lee HM; Jun BG; Lee SH; Kim HS; Kim SG; Kim YS; Kim BS; Jeong SW; Jang JY; Kim YD; Cheon GJ
Korean J Gastroenterol; 2015 Jan; 65(1):35-42. PubMed ID: 25603852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
